Literature DB >> 12459036

Cultured pancreatic ductal cells undergo cell cycle re-distribution and beta-cell-like differentiation in response to glucagon-like peptide-1.

A Bulotta1, H Hui, E Anastasi, C Bertolotto, L G Boros, U Di Mario, R Perfetti.   

Abstract

The intestinal hormone glucagon-like peptide-1 (GLP-1) has been shown to promote an increase in pancreatic beta-cell mass via proliferation of islet cells and differentiation of non-insulin-secreting cells. In this study, we have characterized some of the events that lead to the differentiation of pancreatic ductal cells in response to treatment with human GLP-1. Rat pancreatic ductal (ARIP) cells were cultured in the presence of GLP-1 and analyzed for cell counting, cell cycle distribution, expression of cyclin-dependent-kinase (Cdk) inhibitors, transcription of beta-cell-specific genes, loss of ductal-like phenotype and acquisition of beta-cell-like gene expression profile. Exposure of ARIP cells to 10 nM GLP-1 induced a significant reduction in the cell replication rate and a significant decrease in the percentage of cells in S phase of the cell cycle. This was associated with an increase in the number of cells in G0-G1 phase and a reduction of cells in G2-M phase. Western blot analysis for the Cdk inhibitors, kinase inhibitor protein 1 (p27(Kip1)) and Cdk-interacting protein 1 (p21(Cip1)), demonstrated a significant increase in p27(Kip1) and p21(Cip1) levels within the first 24 h from the beginning of GLP-1 treatment. As cells slowed down their proliferation rate, GLP-1 also induced a time-dependent expression of various beta-cell-specific mRNAs. The glucose transporter GLUT-2 was the first of those factors to be expressed (24 h treatment), followed by insulin (44 h) and finally by the enzyme glucokinase (56 h). In addition, immunocytochemistry analysis showed that GLP-1 induced a time-dependent down-regulation of the ductal marker cytokeratin-20 (CK-20) and a time-dependent induction of insulin expression. Finally, GLP-1 promoted a glucose-dependent secretion of insulin, as demonstrated by HPLC and RIA analyses of the cell culture medium. The present study has demonstrated that GLP-1 induces a cell cycle re-distribution with a decrease in cell proliferation rate prior to promoting the differentiation of cells towards an endocrine-like phenotype.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459036     DOI: 10.1677/jme.0.0290347

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  22 in total

Review 1.  Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.

Authors:  Marzieh Salehi; Benedikt A Aulinger; David A D'Alessio
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

Review 2.  Stem cell therapy for type 1 diabetes mellitus.

Authors:  Cristina Aguayo-Mazzucato; Susan Bonner-Weir
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

Review 3.  Utilizing the GLP-1 signaling system to treat diabetes: sorting through the pharmacologic approaches.

Authors:  David A D'Alessio; Torsten P Vahl
Journal:  Curr Diab Rep       Date:  2005-10       Impact factor: 4.810

Review 4.  Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.

Authors:  K Pabreja; M A Mohd; C Koole; D Wootten; S G B Furness
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 5.  Cholangiocyte proliferation and liver fibrosis.

Authors:  Shannon S Glaser; Eugenio Gaudio; Tim Miller; Domenico Alvaro; Gianfranco Alpini
Journal:  Expert Rev Mol Med       Date:  2009-02-25       Impact factor: 5.600

6.  Insulin secretion decline in Walker-256 tumor-bearing rats is early, follows the course of cachexia, and is not improved by lixisenatide.

Authors:  Débora Luiza Quintilhano; Daniele Romani Miksza; Winny Beatriz de Souza Galia; Mahira Oliveira Ramalho Costa Ramalho; Camila Ferraz Lucena; Maíra Mello Rezende Valle; Maria Fernanda Rodrigues Graciano; Helenir Medri de Souza; Gisele Lopes Bertolini
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-31       Impact factor: 3.000

7.  Pancreatic β-Cell Mass as a Pharmacologic Target in Diabetes.

Authors:  Stephen Hanley
Journal:  Mcgill J Med       Date:  2009-11-16

8.  Effects on glucagon-like peptide-1 secretion by distal ileal administration of nutrients.

Authors:  Xiao Feng; Shuzhe Zhong; Jian Yang; Yong Wang; Jingang Liu
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

Review 9.  Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.

Authors:  Kjeld Hermansen; Lene S Mortensen
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

10.  Mechanisms of KGF mediated signaling in pancreatic duct cell proliferation and differentiation.

Authors:  Benjamin Uzan; Florence Figeac; Bernard Portha; Jamileh Movassat
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.